Injection treatment no help for hamstring injuries, study says

June 25, 2014 by Randy Dotinga, Healthday Reporter

(HealthDay)—An expensive and unusual treatment that relies on components from a patient's own blood doesn't appear to speed recovery from hamstring muscle injuries, according to new research.

The is favored by top athletes, but the study found no benefit from platelet-rich plasma injections, at least when administered in a certain way.

A physician who relies on the largely untested therapy says the new research misses the mark. But the study's lead author stands by the findings, published in the June 26 issue of The New England Journal of Medicine.

"We found no benefit of platelet-rich plasma injections compared to placebo injections" in terms of the time athletes needed to return to playing sports and their risk of getting injured again, said study lead author Dr. Gustaaf Reurink, a sports medicine specialist with Erasmus Medical Center in Rotterdam, the Netherlands.

Hamstrings are muscles at the back of the thigh and crucial to flexing the hip and knee, said Dr. Lewis Maharam, a sports medicine specialist in New York City.

If they're warmed up, the muscles should stretch like warm taffy, Maharam said. But if they're not, they can become inflexible and be torn during exercise.

Injured people will find that "it hurts to run, and it may hurt to walk," he said. "It may hurt all the time. It depends on how big the tear is."

In the past, pro football players with torn hamstrings might need to be kept off the field for eight to 12 weeks to recover through rest and physical therapy, Maharam said. But he said platelet-rich plasma injections have made a big difference.

The goal of the treatment is to attract body-repairing stem cells to the hamstring injury, he said. To do this, a physician sends a patient's blood to a lab for processing to remove platelets and parts of the immune system known as lymphocytes. These are injected into the patient's body at the site of the injury and, at least, according to theory, send a cry for help to stem cells that arrive to save the day.

"When it's done correctly, patients heal in two to three weeks maximum, and they're back running," Maharam said.

There are caveats. There's no research showing that the treatment works on hamstring injuries, and insurance companies won't cover the treatment because it's experimental, Maharam said. He declined to pinpoint the potential cost but said the treatment is for wealthy people and pro athletes.

Study lead author Reurink said single injections cost $500 to $1,000. The number of injections needed, he said, is up for debate.

The treatment is also used for chronic tendon injuries, such as tennis elbow; new ligament and ; knee arthritis; during some orthopedic surgeries, and even for broken bones, according to the American Academy of Orthopaedic Surgeons. However, the orthopedic group said the treatment hasn't been definitively proven for any condition, and the current evidence for the therapy is limited.

In the new study, researchers gave two injections of either platelet-rich plasma or saline (a placebo) to 80 athletes with hamstring injuries. The researchers tracked them for six months.

The researchers reported that the treatment appeared to have no effect. The median time to start playing sports again was 42 days for athletes in both groups. About 15 percent of athletes in both groups re-injured themselves.

Reurink said the treatment might not work because the plasma doesn't do enough to boost the healing process.

Maharam questioned the study, saying the researchers didn't flood the injured hamstrings via the injections or adjust the amount of plasma based on the size of the injury. Reurink responded that the researchers carefully pinpointed the injuries and used the treatment amount recommended by the manufacturer of the system that produced the plasma treatment.

"We do not know whether these results can be generalized to other interventions, such as injections with more fluid," Reurink said. Still, research hasn't shown that other approaches actually work, he said.

Explore further: Clinical trial looks at impact of platelet-rich plasma therapy on tennis elbow

More information: For more about platelet-rich plasma therapy, visit the American Academy of Orthopaedic Surgeons.

Related Stories

Clinical trial looks at impact of platelet-rich plasma therapy on tennis elbow

November 12, 2013
A procedure intended to help heal musculoskeletal injuries called platelet-rich plasma therapy, or P.R.P., has created a big buzz in sports medicine and the media in recent years. Tiger Woods reportedly received the procedure ...

ACL injuries in young female athletes now an epidemic

May 1, 2014
(Medical Xpress)—With young female athletes experiencing an epidemic of ACL knee injuries, a Loyola University Medical Center sports medicine specialist is urging parents to demand that coaches implement injury-prevention ...

Platelet-rich plasma treatment more effective than cortisone for severe hip bursitis

March 14, 2014
Chronic hip bursitis is a common yet difficult condition to treat successfully. A recent study, presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), compared the results of PRP ...

Tendon stimulation the key to repair in 'tennis elbow'

June 11, 2014
New data presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) show that ultrasound-guided injections of growth factors-containing platelet-rich plasma (PRP) are no more effective in treating ...

PRP treatment aids healing of elbow injuries say researchers

February 11, 2012
As elbow injuries continue to rise, especially in pitchers, procedures to help treat and get players back in the game quickly have been difficult to come by. However, a newer treatment called platelet rich plasma (PRP) may ...

Recommended for you

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

'Superbugs' study reveals complex picture of E. coli bloodstream infections

July 18, 2017
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains. Research by ...

Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.